-
The Danish drugmaker's move follows a similar announcement by rival Eli Lilly earlier this month. More than 8 million Americans use insulin, according to the American Diabetes Association.
-
Young Black adults, Mexican Americans and other Hispanic adults experienced the greatest cardiovascular risk factors, according to a study published in the Journal of the American Medical Association.
-
Drug pricing experts predict the move will help other initiatives to bring lower-cost insulin to market and maintain pressure on Eli Lilly to keep its prices down.
-
Lilly said it will cut the list prices for its most commonly prescribed insulin, Humalog, and for another insulin, Humulin, by 70% or more in the fourth quarter, which starts in October.
-
Twitter has been a hotbed for the insulin access movement and activism surrounding other medical conditions - helping propel concern about the prices into policy. Can it continue to win with hashtags?
-
At first glance, it may be hard to recognize the links between climate change and diabetes but they’ve been traced in a number of studies, according to health experts.
-
People who get regular short bouts of exercise are less likely to develop diabetes, dementia and heart disease, a new study finds. And an added benefit - regular movement puts people in a better mood.
-
According to the FDA, Tzield binds to certain immune system cells and delays progression to stage 3 type 1 diabetes.
-
In August, Congress approved a $35 cap on what seniors will pay for insulin, but that change came too late to add to the online tool that helps Medicare beneficiaries compare drug and medical plans.
-
The body mass index — a simple mathematical equation — is tied to a measure of obesity invented almost 200 years ago. On the downside, it can stand between patients and treatment for weight issues. It particularly mismeasures Black women and Asians.